AXA Framlington Health Fund

Select share classes

AXA Framlington Health Fund Z Acc

Category Sector Equity Healthcare


star-filledstar-filledstar-filledstar-filled
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

453.50p

arrow-up5.30p (+1.18%)

Fund Code

FMHEA

B6WZJX0

GB00B6WZJX05

Prices updated as at 08 May 2024
|
Prices in GBX

Investment objective
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.

Dividend information

Dividend information
-
0.23
-
Semi-Annually
28 Jun 2024

Dividend history

Ex-div datePer share amountReinvestment price
01 May 20240.0046344.435
01 Nov 20230.0054343.925
02 May 20230.0048314.126
01 Nov 20220.0038094.149
03 May 20220.0042283.874
01 Nov 20210.0113083.888
02 Nov 20200.0077833.234
01 Nov 20190.0063162.739
01 Nov 20180.0058412.627
01 Nov 20170.0089822.35
01 Nov 20160.008112.261
02 Nov 20150.0039521.988
03 Nov 20140.0031.783
Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.